Inhibition of HMG CoA Reductase and Lipid Peroxidation in The Rats Liver by Selected Zingiberaceae
Abstract
Keywords
Full Text:
PDFReferences
Bhalavi, V., Deshmukh, P., Atram, M., Mahajan, B., 2015, Study of hypertension and hyperlipidemia in the adolescent of central India, International Journal Of Recent Trends In Science And Technology, 10(3): 495–498.
Blum, A., 2014, HMGâ€CoA reductase inhibitors (statins), inflammation, and endothelial progenitor cells—new mechanistic insights of atherosclerosis, Biofactors, 40(3): 295–302.
Felfoul, I., Borchani, M., Samet-Bali, O., Attia, H., Ayadi, M A., 2017, Effect of ginger (Zingiber officinalis) addition on fermented bovine milk: rheological properties, sensory attributes and antioxidant potential, Journal of New Sciences, 44: 2400–2409.
Gholampour, F., Ghiasabadi, F. B., Owji, Seyed M., Vatanparast, J., 2017, The protective effect of hydroalcoholic extract of Ginger (Zingiber officinale Rosc.) against iron-induced functional and histological damages in rat liver and kidney, Avicenna journal of phytomedicine, 7(6): 542.
Hasimun, P., Adnyana, I K., Valentina, R., Lisnasari, E., 2016, Potential alpha-glucosidase inhibitor from selected Zingiberaceae family, Asian Journal of Pharmaceutical and Clinical Research, 9: 164–167.
Kajal, A., Kishore, L., Kaur, N., Gollen, R., Singh, R., 2016, Therapeutic agents for the management of atherosclerosis from herbal sources, Beni-Suef University Journal of Basic and Applied Sciences, 5(2): 156–169.
Khandouzi, N., Shidfar, F., Rajab, A., Rahideh, T., Hosseini, P., Taheri, M. M., 2015, The effects of ginger on fasting blood sugar, hemoglobin A1c, apolipoprotein B, apolipoprotein AI and malondialdehyde in type 2 diabetic patients, Iranian journal of pharmaceutical research: IJPR, 14(1): 131.
Mendis, S., Puska, P., Norrving, B., 2011, Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization.
Moriel, P., Plavnik, Frida L., Zanella, M. T., Bertolami, M. C., Abdalla, DSP., 2000, Lipid peroxidation and antioxidants in hyperlipidemia and hypertension, Biological Research, 33(2): 105–112.
Qudoos, A., Nia, K., Hakro, S., Murad, S., 2016, Single Blind Placebo-Controlled Study On Comparision Of Effects Of Zingiber Officinale Before And After Treatment In Hyperlipidemia, Journal of Drug Delivery and Therapeutics, 6(3): 90–92.
Rader, D. J.., Hovingh, G. K., 2014, HDL and cardiovascular disease, The Lancet, 384(9943): 618–625.
Rouhi-Boroujeni, H., Rouhi-Boroujeni, H., Heidarian, E., Mohammadizadeh, F., Rafieian-Kopaei, M., 2015, Herbs with anti-lipid effects and their interactions with statins as a chemical anti-hyperlipidemia group drugs: A systematic review, ARYA atherosclerosis, 11(4): 244.
Selvam, R., Kurien, T. B., 1987, Induction of lipid peroxidation by oxalate in experimental rat urolithiasis’, Journal of Biosciences, 12(4): 367.
Shidfar, F., Rajab, A., Rahideh, T., Khandouzi, N., Hosseini, S., Shidfar, S., 2015, The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes, Journal of Complementary and Integrative Medicine, 12(2): 165–170.
Srinivasan, K., 2017, Ginger rhizomes (Zingiber officinale): a spice with multiple health beneficial potentials, Pharma Nutrition, 5(1): 18–28.
Tohma, ., Gülçin, İ., Bursal, E., Gören, A. C., Alwasel, S. H., Köksal, E., 2017, Antioxidant activity and phenolic compounds of ginger (Zingiber officinale Rosc.) determined by HPLC-MS/MS, Journal of Food Measurement and Characterization, 11(2): 556–566.
Tripathi, P., Singh, A., 2015, Indigenous Asian Plants against Cancer: A Comprehensive Review, International Journal of Plant Research, 5(4): 80–86.
Trpkovic, A., Resanovic, I., Stanimirovic, J., Radak, D., Mousa, S.A., Cenic-Milosevic, D., Jevremovic, D., Isenovic, E. R., 2015, Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases, Critical reviews in clinical laboratory sciences, 52(2): 70–85.
Wells, B. G., DiPiro, J. T., Schwinghammer, T. L., DiPiro, C. V., 2014, Pharmacotherapy Handbook, 9/E. McGraw Hill Professional.
Würtz, P., Wang, Q., Soininen, P., Kangas, A. J., Fatemifar, G., Tynkkynen, T., Tiainen, M., Perola, M., Tillin, T., Hughes, A. D., 2016, Metabolomic profiling of statin use and genetic inhibition of HMG-CoA reductase, Journal of the American College of Cardiology, 67(10): 1200–1210.
DOI: http://dx.doi.org/10.12928/pharmaciana.v8i2.9430
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Patonah Hasimun, Agus Sulaeman, Hendra Mahakam Putra, Heni Lindasari
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Office: Faculty of Pharmacy, Universitas Ahmad Dahlan
Jl. Prof. Dr. Soepomo, S.H., Janturan, Warungboto, Umbulharjo, Yogyakarta, Indonesia
Kode pos 55164
Email: pharmaciana@pharm.uad.ac.id